Diffuse Large B-Cell Lymphoma

News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me

Diffuse Large B-Cell Lymphoma
Dec 20, 2024, 18:00 | Science
Real-world data on the clinical features, therapy patterns, and outcomes of older adults with diffuse large B-cell lymphoma in Latin America
Cancer and Aging Research Group shared a study by Myrna Candelaria et al. on X:…
Dec 20, 2024, 10:22 | Insight
Jame Abraham: Glotiftamab combination shows safety and efficacy for relapsed large B-cell lymphoma
Jame Abraham,Chairman of the Department of Hematology and Medical Oncology at Cleveland Clinic, shared a…
Nov 14, 2024, 12:33 | Insight
Ajay Major: Liso-cel in DLBCL with secondary CNS diagnosis by Jennifer Crombie
Ajay Major, Assistant Professor of Medicine at the University of Colorado School of Medicine, shared…
Oct 14, 2024, 16:46 | Blog
Raul Cordoba: End points in clinical trials in diffuse large B-cell lymphoma
Raul Cordoba shared on X: "Hematology End points in clinical trials in diffuse large B-cell…
Aug 23, 2024, 14:13 | Insight
Oncology Brothers: Discussions around the algorithm for DLBCL
Oncology Brothers shared on X: "This is the algorithm we have used during our discussion…
Jul 29, 2024, 13:35 | Insight
Megan Melody: Cellular therapy and bispecific antibodies for large B-cell lymphoma
Kate Cwynarski, Haematogist-Oncologist in Lymphoma and CLL at University College London Hospital, shared a post on…
Jun 19, 2024, 04:44 | Cancer Types
Diffuse Large B-Cell Lymphoma: What patients should know about
What is diffuse large B-cell lymphoma? Diffuse large B-cell lymphoma (DLBCL) is an aggressive (fast-growing)…
Apr 29, 2024, 17:36 | Blog
Kate Cwynarski: Fantastic talk by Marco Ruella on CAR-T
Kate Cwynarski, Consultant Haematologist at University College London Hospitals NHS Foundation Trust, recently shared on…
Jan 19, 2024, 18:00 | Blog
Prashant Mehta: My thoughts on developments in DLBCL management
Prashant Mehta, Senior Consultant and Assistant Professor in the Department of Medical Oncology/Hematology-oncology and Bone…
Dec 8, 2023, 12:40 | Insight
Amar Kelkar: We hope putting out independent cost-effectiveness analyses like this will encourage others to join
Amar Kelkar, Physician at the Dana-Farber Cancer Institute and an Instructor in Medicine at Harvard…
All: 10 Posts: 1 - 100
Special Coverage